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Asymptomatic Caniage of Neisseria 
meningitidis in Schoolchildren in a Primary 
School in Istanbul, Turkey 
M. Punar, A.A. Ca&w, H. Ozsut, H. Eraksoy, S .  Calangu, 
M. Dilmener. Dept. of Clinical l3acteriolOgy G Infeaious Diseases, 
Istanbul Faculty ofMedicine, Istanbul University, Istanbul, Turkey 
Objectives: To estimate the extend of asymptomatic carriage of 
Neisseria meningitidis in schoolchildren in a primary school, in Istan- 
bul, T u r h .  
Methods: 81 students in age of 9-11 years old were randomly 
selected in a primary school in an urban part of Istanbul. The survey 
was performed in late winter. Throat swabs were plated on selective 
GC medium. Plates were incubated at 35°C in 10% C02 for 24-48 
hours. All oxidase positive isolates with Gram-negative diplococcal 
morphology were further identified with API NH as N. meningitidu. 
Serogroups were determined by agglutination with antisera ( h a p ,  
Habana, Cuba) for A, B, C, D and W135, and polyvalent antisera 
(Mimap, Habana, Cuba) for WXYZ capsular polysaccharides. 
Results: A? meningitidis was isolated in 17 samples. Of 81 subjects 
21% were asymptomatic carriers of N. meningitidis. None of the 
samples harboured A? gononhoeae. Four serogroups were represented; 
C (4 isolates), A (2 isolates), B (2 isolates) and W135 (1 isolate). 
Nearly 50% of the isolates (n = 8) were nonserogroupable. 
Conclusion: In spite of small study population, these data shav 
the threat for the development of N. meningitidis disease epidemics. 
However, there has not been any case of meningococcal infection 
among the schoolchildren screened for at least last five years. 
-1 Hearing Impairment in Patients with Bacterial 
K. Karovski, Z. Milenkovic, A. Bogdanovska, V Kirova. Clinic of 
Infectious Diseases, Skopje, R. Macedonia 
Fifteen patients with hearing impairment during the bacterial 
meningitis, have been analyzed, retrospectively Hearing impairment 
(conductive and sensorineural hearing loss) assessed with audiogram 
and brain stem-evoked responses, was the most fkequent sequela 
(68.18% 15/22), accwnted for 8.06% of 186 survived, amongst 
the 221 treated patients with bacterial meningitis during the last 
5-year period at Clinic for Infectious Diseases in Skopje. None of 
the patients had auditory troubles before the actual disease. Hearing 
impairment was noted in 11 (11.11%) of 99 healed patients with 
bacterial meningitis with initially desturbed state of consciousness, 
that we consider being a poor prognostic sign related to thls sequela. 
The etiology of bacterial menigitis in patients with hearing im- 
pairment was: Sh. pneumoniae (5 cases), Staph. aureus (2 cases), H. 
influenzae and M. pneumoniae, each in 1 case. In 6 patients with 
bacterial meningitis and hearing impairment, the etiologic agent has 
not been confirmed in cerebrospd fluid. It is worth noted the 
high percent (33.04%) of etiologicaly unconfirmed cases with bac- 
terial meningitis. It is also worth noted that 54 (24.44%) of 221 
patients with bacterial meningitis in this series simultaneously suf- 
fered of otitis media and/or mastuiditis. 
In the comparative study of inihally collected labor-biochem. pa- 
rameters, higher levels of cerebrospd fluid lactate, pleocytosis and 
proteinorachy, and lower levels of glycorachy have been detected in 
patients with hearing impairment, compared with other healed pa- 
tients. The high levels of albumin index, cerebrospinal fluid - IgG 
and IgG-index; and IgG-synthesis in CNS for 24 hours have been 
found also in the group patients with bacterial meningitis and hear- 
ing impairment, compared with other healed patients. 
Meningitis 
1 PI302 I Immunologic Changes in the Cerebrospinal 
Fluid at Infections of Central Neural System 
Tz. Doichinova, I? Ilieva, M. Atanasova. Department oflnfectious 
Diseases, Medical university, Pleuen, Bulgaria 
Objectives: The study is carried out on cerebrospd fluids ob- 
tained b m  50 patients with meningitis purulenta and 50 patients 
with meningitis serosa, treated at the C h c  of Infectious Diseases 
at the University Hospital, Pleven. As conhol is used normal cere- 
the central neural system. 
Methods: The patients were diagnosed on the ground of a com- 
plex assessment including anamnestic, clinical and routine panclini- 
cal parameters, as well as results obtained b m  routine cerebrospinal 
fluid b m  the OLL groups. Concentration of immunoglobukn in 
cerebrospinal fluid observed of methods Mancini l., 1965. 
Results: The levels of I&, IgM and IgA classes at patients with 
purulent meningitis were statistically sigmficantly increased in com- 
parison with those ones established at patients with serous me%- 
tis. It would be emphasised the rnuldold increased I g M  level which 
has not been observed in normal cerebrospinal fluid - meningitis 
purulent - X IgG - 329.9 zk 213.2 mg %, IgA - 72.4 f 48.7 q / L ,  
IgM - 11.2 f 9.3 mg/L; meningitis serous - X I& - 36.9 f 17.3 
mg/L,IgA-7.5f5.7mg/L,IgM-l.lfl.O9mg/L. 
Conclusions: The established rnultifold increased levels of the 
three main classes immunoglobulins, at purulent meningitis have 
weighty substantial importance and they could be used as a d&er- 
entially diagnostic test, when the changes in the cerebrospinal fluid 
are not enough categorically to be decided whether the meningi- 
t i s  is serous or purulent one, and hence the beginning of early and 
dequate therapeutic treatment. 
brospinal fluid f h m  50 patients with non-inflamma tory diseases of 
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I P I  303 I Recovery of Small Colony Variants of 
Staphylococcus aureus Following Gentamicin 
Bead Placement for OsteomyeYiis 
C. w n  ES', D. Bettin', R. Proctor'*3, N. Lindner'.', G. Peters'. 
'Inst. ofMed. Microbiol., Univ. o fMi insfq  Germany, 'Dept. ofOrthop 
Surgery, Univ. OfMunstq Germany, 'Depts ofMed. and Med. 
Microbiol. /Immunol., Uniu. of Wisconsin, Madison, USA, 4Dept. of 
Orthqp., Univ. of Florida, Gainesville, U S A  
Objectives: Recently, S. aureus s m a l l  colony variants (SCVs) have 
been shown to persist in vitro withm cultured endotheld cells and 
to cause perslstent and antibiotic resistant infections in humans. Be- 
cause gentamicin can very reproducably select for electron transport 
deficient-SCVs, we carefdy screened specimens b m  patients with 
osteomyelitis who had received gentamicin beads. 
Material and Methods: Over an 18 month period bone spec- 
imens b m  patients with suspected osteomyelits were evaluated for 
S. aureus SCVs. Only patients with cultures that contained S. aureus 
were included. Patients were divided on the basis of previous place- 
ment of gentamicin beads in their bone. Isolates were recognized as 
SCVs ifthey grew as very small, nonpigmented colonies and showed 
an auxoaophc requirement for hemin, menadione or *dine. 
Results: SCVs were recovered in 4 of 4 patients that had previous 
gentamicin beads placement for osteomyelitis whereas no SCVs were 
recovered in 10 patients that had not received gentamicin beads. 3 
of 4 patients with SCVs had large and small colony types isolated 
6vm sequential cultures. These isolates were found to be clonal 
even though the colony-morphology was very different. MICs for 
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gentamicin were up to 32-fold higher for the SCVs as compared 
to the parent strain. Late recurrences (21 year) were only seen in 
patients with SCVs. 
Conclusions: The recovery of S. aureus SCVs h m  patients with 
osteomyelitis previously treated with gentamicin beads suggests that 
the slow release of gentamicin into the local environment may be 
involved in the selection of SCVs. Late recurrences should alert the 
laboratory personnel to carefully search for SCVs and the chc ian  
to suspect a more antibiotic-resistant subpopulation. 
[p13041 Pathogenesis and Treatment (Rx) of 
Experimental Endocarditis (EE) Due to 
Ciprofloxacin-Induced Small Colony Variants 
(cipro-SCVs) of Staphy/ococcus aureus 
J.M. Entenza, I?. Francioli, M.P. Glauser, I?. Moreillon. Division $ 
Infertious Diseases, CHUY Lausanne, Switznland 
Background and Objective: Gentamicin (gents)-induced SCVs 
of S. uureus may cause infection and Rx failure. In the present study, 
we further investigated the pathogenic and therapeutic relevance of 
a new kmd of cipro-induced S. aureus SCVs, using the rat model of 
EE. 
Methods and Results: Incubation of lo7 &/ml cultures of 
a cipro-susceptible (4) strain of S. aureus (MIC 0.12 mg/L) with 
2-4x MIC of cipro generated cipro-resistant (-R) derivatives (MIC 
4-8 mg/L) with medium and small colony sizes. Cipro-R SVCs 
were stable upon regrowth in cipro-free medium, had an unaltered 
biotype, and were clumping and coagulase positive. Cipro-SCVs 
were also less susceptible to levofloxacin. Unlike genta-SCVs, they 
were genta-S and prototrophes for both menadione or thiamine. 
EE was produced by inoculating rats with lo7 cfu of the cipro-S 
parents or the cipro-R SCVs. Both organisms infected 100% of 
controls and resulted in similar bacterial densities in the vegetations 
(LoglO cfu/g = 7.8 f 1.3 versus 7.3 f 1.1, resp.). SCVs remained 
stable after in vivo passage. Three-days Rx with human-like kinetics 
of oral cipro (750 mg b.i.d) cured 717 rats infected with the parents, 
but 0/9 rats infected with the cipro-R SCVs (P  < 0.05). Moreover, 
R x  did not decrease vegetation bacterial titers in animals infected 
with the cipro-SCVs. 
Conclusion: Cipro Rx may select for stable cipro-R SCVs, 
which can induce EE and result in Rx failure. The clinical impor- 
tance of such SCVs for quinolone resistance and Rx fdure deserves 
further attention 
I PI305 I Trovafloxacin (trova) Treatment (Rx) of 
Experimental Endocarditis (EE) Due to 
Penicillin-Susceptible (pen-S) and -Resistant 
(pen-R) Streptococci 
J.M. Entenza, J. VouiUamoz, M. Giddey, MI! Glauser, I?. Moreillon. 
Centre Hospitalier Univenituire Wudois, Lausanne, Switzerland 
Objective: To investigate the efficacy of mva, a new quinolone 
with enhanced activity against Gram-positive pathogens, in the treat- 
ment of EE due to viridans group streptococci. 
Methods and Results: One pen4 and one pen-R streptococcal 
isolates were used (S. sanguis DU and S. mitis 531; MIC of Pen = 
0.006 mg/L and 2 mg/L resp.). Both strains were highly susceptible 
to trova (MIC = 0.06 mg/L). Time-kill experiments in Brain Heart 
Infusion showed that both strains were killed by trova concentrations 
mimicking either peak (2.5 mg/L) or trough (0.5 mg/L) drug levels in 
human serum (loss of 2 3  LoglO cfu/mL after 24 h ofRx). Addition of 
50% serum to the medium did not alter killing at peak concentration, 
but blocked killing at trough serum level. Rats with EE were treated 
for 3 days with human-hke kinetics of either oral trova (200 mg once 
daily) or i.v. ceftriaxone (cro; 2 g once daily). Results were CP < 0.05 
vs controls; t, P < 0.05 versus the other drug): 
Antiblonc Regimen Mean f SD log10 ch/g of vegetation (infected ntdtotd) 
S. ronguir "Du" S. milis 531 
Controls 9.3 k 0.2 (818) 8.8 f 0.4 (7/7) 
Trow 7.0 f 3.8' (7/7) 
CrO 3.8 f 2.2'.t (4/7) 6.7 f 2.0 U / 7 )  
5.7 f 1.8* (88) 
Conclusion: Trova sigNficantly reduced vegetation bacterial den- 
sities in EE due to both test organisms. No resistant bacteria were 
selected. Longer therapy with trova and/or higher dosages deserve 
further consideration. 
Ip13061 Trovafloxacin (trova) Treatment (Rx) of 
Experimental Endocarditis (EE) due to 
Ciprofloxacin-susceptible (cipro-S) 
Methicillin-Resistant Staphylococcus aureus 
(MRSA) 
J.M. Entenza, J. Vouillamoz, M. Giddey, M.E? Glauser, I?. Moreillon. 
CHUY Lausanne, Switzerland 
Objective: To investigate the efficacy of tmva, a new quinolone 
with enhanced activity against Gram-positive pathogens, in the treat- 
ment of EE due to cipro-S MRSA. 
Methods and Results: Two cipro-S isolates of MRSA were used 
(strain COL and P8; cipro MICs = 0.25 mg/L and 0.5 mg/L resp.). 
Both strains were highly susceptible to trova (MICs = 0.03 mg/L 
for COL and 0.06 mg/L for PI). Time-kill experiments in Mueller 
Hinton broth showed that both strains were killed by trova concen- 
trations mimicking either peak (2.5 mg/L) or trough (0.5 mg/L) 
drug levels in human serum (loss of 2 4  LoglO &/mL after 24 h 
of Rx). Addition of 50% serum to the medium did not alter killing 
at peak serum level, but blocked killing (<2 LoglO) at trough level. 
Rats with EE were treated for 3 days with human-hke kinetics of 
either oral trova (200 mg once daily) or i.v. vancomycin (vanco; 1 g 
bid.). 
Results C P  < 0.05 vs controls): 
Antibiotic Regimen Mean f SD log &/g of ~getauon (# infcced nc;/tod) 
MRSA COL MRSA P8 
Conmls 7.0 f 0.8 (5/5) 7.8 f 0.7 (9/9) 
TrOw 3.0 f 1.9' (2/8)' 2.3 f 0.8' (2110). 
vanco 5.3 f 3.1 (518) 4.3 i 2.8' (4/8) 
Conclusion: Once daily dose of trow was as effective or more 
than vanco against EE due to cipro-S MRSA. No resistant variants 
were selected either in vitro or in vivo. Trova might be considered 
for Rx of cipro-S MRSA infections. 
m] Trovafloxacin Delays the Antibiotic-Induced 
Inflammatory Response in Experimental 
Pneumococcal Meningitis 
R. Nau I ,  G. Zysk I ,  H. Schrmdt I ,  ER. Fischer ', A. Stringaris ', 
K. Stuertz', W. Briick'. 'Department $Neurology, Univmity of 
Gttingen, Germany, 'Department 4 Neuroputhology, University of 
Giittingen, Germany 
Streptococcus pneumoniae type 3 ( s P ~ ;  2 x lo8 C F U / ~ )  was 
exposed to either mvafloxacin or ceftriaxone (10 mg/l) for 3 h. The 
resulting inocula were given intracisternally to antibiotic-pretreated 
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rabbits (0.375 mg every 3 h over 9 h; n = 12). Trodoxah-treated 
SP3 induced consistently lower CSF WBC counts than ceftriax- 
one-treated SP3 (median 543/mm3 v 2568/mm3 at 6 h, p = 0.03; 
2207/mm3 v 4560/mm3 at 18 h, p = 0.03). TNF and IL-1 levels 
in CSF did not M e r  significantly. In a second study, meningitis was 
induced with lo6 C N  SP3 intracisternally. Rabbits (n = 20) were 
treated 12 h later with either intravenous trodmacin or ceftnax- 
one (10 mg/kg loadmg, 10 mg/kg/h maintenance). Trodoxacin 
produced sigruficantly lower median TNF and IL-1 CSF levels com- 
pared with cefaiaxone at 14 h (26 U/ml v 141 U/ml, p = 0.02; 
455 pg/ml v 1399 pg/ml, p = 0.02). The median CSF WBC were 
1519/mm3 and 5307/mm3 (ns). After 24 h, CSF WBC was ap- 
proximately equal in both groups. TNF and IL-1 were bgher in 
trovatloxacin-treated animals (61 U/ml v 7 U / d ,  p = 0.001; 4320 
pg/ml v 427 pg/ml, p = 0.006). The in vivo bactericidal rates of both 
antibiotics were sirmlar (median Alog CFU/mVh -0.26 v -0.29). 
The increase of CSF lactate during trovafloxacin therapy was lower 
than with cefiriaxone (median 2.0 v 4.0 mmol/l, p = 0.03). 
In conclusion, SP3 treated in vitro with trodoxacin induced sig- 
nificantly less CSF leukocytosis than ceftriaxone-treated SP3. M- 
host reaction induced by the initiation of antibiotic therapy, probably 
by slowing the release of proinflammatory bacterial products. 
ter intracisternal inoculation, m d o x a c i n  delayed the inflamma tory 
Ip1308I The Effect of Dexamethasone on the Levels of 
Cerebrospinal Fluid Cytokines (TNF-a, IL-6) in 
the Childhood Bacterial Meningitis 
N. Giirses, A. Bay, A.G. Kalayci. Ondokuz Mayis Uniuerzity School .f 
Medicine, Department of Pediatriq Samsun, Turkey 
Routine use of steroids as adjunctive treatment of bacterial meningi- 
tis remam contraversial. We have carried out a prospective, placebo 
controlled, double b h d  study of dexamethasone in 60 children with 
acute bacterial meningitis. The patients were randomly assigned to 
receive either placebo (29) or dexamethasone (31) in addition to 
optimum antibiotic treatment (100 mg/kg daily cefiriaxone). Dex- 
amethasone (0.15 mg/kg) was given 15 to 20 minutes before the first 
dose of cefrriaxone and was continued every 6 hours for four days. 
Cerebrospinal Fluid (CSF) samples were taken on admission and af- 
ter 48 hours and 9 days. On the same days IL-6 and TNF-a levels 
were measured in CSF samples. Dexamethasone treated patients had 
sigdicantly lower IL-6 and higher glucose levels at 4 8 ~  hour (p < 
0.05). In conhary to this TNF-a levels were compereable on ev- 
ery three occasions in both groups (p =- 0.05). As compared with 
placebo group, dexamethasone group become afebrile earlier (25.9 
vs 52.8 hours p i 0.05). No severe adverse effects were found in 
dexamethasone group. Long term follow up (4-1 1 month) revealed 
neurological or audiological seguelae in 7 subjects of dexamethasone 
group and in 11 subjects of placebo group (p z 0.05). 
We concluded that dexamethasone is beneficial in decreasing some 
cytokines in CSF but not efficious in sequelae rates in chddren wth  
bacterial meningitis. 
I P I  309 I The Restoration of the Blood Brain Barrier 
(BBB) Physiological Functions: The Possible 
Role of CSF-IL6 
R. Ceccarefi I ,  E. Mantero 
C. Palmero 
lnfecous Dk., Giannina Gaslini Institute, Genoa, Italy, zNeurosurgicd 
Service, Giannina Gaslini Institute, Genoa, Italy 
Objectives: To evaluate the clearance of CSF IL-6, during events 
with and without BBB injury as ventricular shunt infections and 
A. Cama ', R. Frulio ', S. Ratto ', 
L. Andreussi', C. Jannuzd'. '2nd Department .f 
intracranial tumors, by a long term external ventricular b a g e  
system (EVD). 
Methods: We studied (A) 8 patients (5 males, 3 females me- 
dun age 18 months) with a ventricular shunt infection and short 
illness duration (CSF negative culture within 9 days); (B) 5 patients 
(4 males, 1 female medun age 3.6 months) with ventricular shunt 
infection and progressive disease or therapy adverse effects; (C) 3 
patients (2 male, 1 female median age 41.3 months) with medul- 
loblastoma. CSF was obtained at EVD implant (LO) and by EVD at 
24 h (tl), 48 h (tz), 72 h (a), 96 h (t4), 144 h (ts), 216 h (t6) and 
finally 360 h (tl5) after EVD implant. 
Results: The mean CSF drainage was in all patients 10 
ml/kg/day. The mean normalisation time of CSF biochemical data 
was 12.6 days in (A) and > 15 days (tl5) in (B): in (C) few abnor- 
malities were observed up to t3, probably related to EVD implant. 
The clearance of CSF-IL6 at t15 was 98% in (A), and 66% in (B): 
low and u d o r m  values were observed n (C). 
Conclusions: Increasing levels of IL-6 were detected only after 
a BBB injury and a relationship between IL-6 clearance and the 
restoration of BBB physiological functions was described. 
Neutralizing Anti-IL-8 Antibody Blocks 
Pleocytosis in Experimental Meningitis 
J. Vaxelairel, N.N. Voitenok', B. Moser3, U. Junker ', S. Kunz', 
0. Zak ' , T. O'Reilly '. 'Nouartis Pharma Inc., Basel, Sw'tzerland, 
'Institute cf Hematology, Minsk, Belarus, n o d o r  Kochev Institute, 
Bern, Switzerland 
Objectives: To determine the role of pro-inflammatory chemokine 
IL-8 in inducing d u x  of neutrophils into the subarachnoid space 
(SAS) during meningitis by use of a neutralizing anti-rabbit IL-8 
monoclonal antibody (WS-4). 
Methods: Sterile meningitis was induced in rabbits by the in- 
tracisternal (IC) injection of 25 ng of LPS. Rabbits were adminis- 
tered WS-4 either intracisternally (500 pg, along with LPS) or i.v. 
(10 mg, 20 mins before LPS administration). CSF leukocytes (WBC) 
and TNF were determined as indicators of SAS mflammation. 
Results: IC injection of LPS induced a profound influx ofWBCs 
(8693 f 1392 WBC/wL CSF) after 4 h, whch slowly declined to 
4427 f 762 WBC/pL CSF by 8 h. 17 administration of WS-4 
decreased the peak WBC level (to 4485 f 881 WBC/pL CSF), but 
did not otherwise alter the pattern of WBC influx in response to 
LPS. The concentration of WS-4 in CSF was initially -125 to 150 
yg/mL CSE This amount of antibody was sufficient to neutralize 
the activity of 1.75 n g / d  rabbit IL-8 in inducing neutrophil influx 
into rabbit skin; ehls would be considered a high IL-8 concentration 
in clinical CSF samples. In contrast, the i.v. injection of 10 mg of 
WS-4 dramatically blocked WBC influx into CSF (peak 544 f 216 
WBC/pL CSF at 6 h). The initial WS-4 concentration was -33 
to 40 pg/mL blood. Intravenous WS-4 shghtly reduced peak CSF 
TNF activity (at 2 h) associated with IC LPS (WS-4: 37 f 9 ng/mL; 
control: 47 f 9 ng/mL; p < 0.05). 
Conclusions: Antibody-neutralization of CSF IL-8 appears to 
have little effect on pleocytosis whereas neutralization of bloodstream 
IL-8 activity (presumably near the brain endothelia) blocks WBC 
influx. IL-8 withu~ CSF may not be a major factor in inducing SAS 
inflammation. 
I PI311 I The Effect of Delayed Antibiotic Treatment 
during Experimental Meningitis 
A. Plunney, T. O'Reilly. Novartis Pharma lnc., Basel, Switzerland 
Objectives: The pre-treatment interval (PTI) is the time between 
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pathogen invasion and the initiation of treatment. Reduced antibi- Miscellaneous experimental infections 
otic efficacy occurs with long PTIs. T h  study investigated the effect 
of PTI on bacterial clearance and exacerbation of inflammation dur- 
Methods: Rabbits were intracisternally inoculated with -lo3& 
Haemophilus inyuenzae type b and treated with 100 mg/kg ceferiax- 
one (CTX) iv after either a 6 or 12 h PTI. 
~1313 Levels of TNF-a and Number of 
Polymorphonuclear Neutrophils in 11-12 
Treated BALBIc Mice with Pseudomonas 
aenrginosa Lung Infection 
ing experimental meningitis. El
, I  
Results: Bacteria were eramcated fiom the CSF at a faster rate 
following the 12 h PTI (-0.70 log &/mL/h) as compared to the 6 
h PTI (-0.47 log cfu/mL/h). Although a 12 h PTI allowed higher 
peak antibiotic CSF penetration (12 h PTI: 31 f 1.7 pg CTX/mL 
C. Moser, D. Gosselin I ,  H.K. Johansen, Z .  Song, N. H0iby. 
Deparhnent ofclinical Microbioloa, Rigshospifalet, Copenhagen, 
Denmark, 'Centrefor the study ofHost Resistance, McCill University, 
Montreal, Canada 
CSF 6 h PTI: 9.1 f 2 pg  CTX/mL CSF), higher CTX levels 
did not increase kill rates in vitro. CTX lost 'cidal activity in vitro 
at high bacterial densities which was not reflected in vivo after a 
12 h PTI. Treatment-associated exacerbation of host dammatory 
response was attenuated at the late PTI. CSF leukocyte (WBC) levels 
increased after a 6 h PTI ( h m  370 f 192 WBC/pL CSF before 
treatment to a peak level of 5343 zk 1518 WBC/pL CSF), whde 
the 12 h PTI group demonstrated no change in CSF WBC levels 
following treatment (-5000 WBC/fiL CSF). TNF levels increased 
to 24-fold the pre-treatment time levels after a 6 h PTI (fbm 2 f 
0.7 ng TNF/mL CSF to a peak of 48 zk 15 ng TNF/mL CSF), 
whde only a 3-fold increase occurred after a 12 h PTI (72 f 31 ng 
TNF/mL CSF to a peak of 198 f 56 ng TNF/mL CSF). 
Conclusions: Delay of treatment apparently does not reduce an- 
tibiotic effectiveness in meningitis, but reduces antibiotic-induced 
exacerbation of subarachnoid space inflammation. 
Ip1312) Tumor Necrosis Factor-a Contributes to 
Apoptosis in Hippocampal Neurons during 
Experimental Neonatal Meningitis 
S.L. Leib I ,  I .  Bogdan I ,  L. Chow ', M.G. Tauber '. Infectious 
Diseasec Divisions, University Hospital, Batel, Switzerland, 'Sun 
Francisco General Hospifal, University of Calfornia, San Framjco, 
C a l f r n i a ,  USA 
Objectives: The present study was performed to evaluate the role 
of tumor necrosis factor4 (TNFa) in the pathogenesis of neu- 
ronal injury in a model of neonatal meningitis caused by group B 
streptococci (GBS). 
Methods: Eleven day old rats were infected intracisternally with 
10 ~1 of GBS in saline (loglo 5.9 f O.l/ml) and randomized for 
treatment with a monoclonal antibody against T N F 4  (TNFmAb: 
20 mg/kg) or s h e  intraperitoneally (i.p.) in a single dose at the 
time ofinfection. In a second experiment, the antibody (170 pg/40 
p.1) or s h e  were administered bectly innacisternally (i.c.). 
Results: Histopathology after 24 h showed two forms of neuronal 
injury: 1.) cortical necrosis; 2.) apoptosis in the hippocampal dentate 
gyrus. Treated showed sigmficantly lower neuronal injury 
scores (median [range]) in the hippocampus than controls both for 
i.p. (p = 0.01) and i.c. (p < 0.05) admimstration of the antibody, but 
had similar cortical injury and CSF m&unmation: 
Cortcx IGpp0cvnp"s 
Conml Treated Conrrol Tiented 
TNFmAb 1.p. 2.9 IG5.81 2.4 [04.4] 3.9 IM.21 1.3 (04.31 
TNFmAbm. 3.5 [0-5.0] 2.0 [0-5.6] 3.1 [W.3] 1.2 [W.2] 
Conclusions: TNF-Q' played a critical role in neuronal apoptosis 
in the hippocampus, while it was not essential for the development 
of mhnmation and cortical injury in this model. 
Objectives: The chronic Pseudomonas aenrginosa (PA) lung infection 
in Cystic Fibrosis (CF) is characterized by a Th2-like immune re- 
sponse with a pronounced antibody response and microcolonies of 
biofilm embedded PA surrounded by PMNs. Previously we found 
that IL-12 treatment of Th2 reacting BALB/c mice with PA lung 
infection delayed mortality, decreased I L 4  and increased IFN-y pro- 
duction by spleen cells. 
Methods: To investigate this mechanism further we challenged 
41 BALB/c mice with 2.4 x lo7 CFU/ml of PA Twentyone mice 
were treated with IL-12 1.0 mg/day i.p. &om one day prior to 
challenge unnl day 5. Twenty control mice were treated with PBS. 
All mice were sacrifized at day 7. Spleen cells were stimulated with 
antigens or mitogens. Concentrations of IFN-)I, IL-4 and TNF-a 
were determined in supernarants by ELISA. Lungs were prepared for 
histopathology and bacteriology. 
Results: In supernatants fhm stimulated spleen cells we deter- 
mined a signtficantly lower IL-4 (p < 0.01) and a sigdcantly hgher 
T N F 4  (p < 0.02) concentration in IL-12 treated mice. In these 
mice we also found significantly more mice with acute inflammation 
and microabscesses (p < 0.025) compared to non-treated controls (n 
Conclusion: In conclusion we find that IL-12 treatment of 
BALB/c mice during PA lung infection benefits PMN lung inflam- 
mation and this might be mediated through T N F 4  production. 
= 12). 
p] Effects of Radix Angelicae Sinensis, Qingkailing 
and Shuanghuanglian on a Rat Model of 
Chronic Pseudomonas Aemginosa Pneumonia 
ZJ Song', H.K. Johansen', C. Moser', V Faber', A. Kharazmi', 
J. Rygaard ', N. H0iby I .  'Wt. Clin. MiuobioloB, Copenhagen, 
Denmark, 2Dept. Communicable G Eopical Diseases, Copenhagen, 
Denmark, Rt&hospifalet, and Bartholin Imtituttet, Copenhagen, 
Denmark 
Objectives: To screen the effective drugs h m  Chmese herbal 
medicine for the treatment of chronic Pseudornonas aeruginosa lung 
infection, 
Methods: Chinese herbal medicine, Radix angelicae sinemis 
@ A S ) ,  Qingkailing (QIU) and Shuanghuanglian (SHL) were used on 
a rat model of chronic I! amginosa lung infection mimicking cystic 
fibrosis (CF), which was made by an inuatracheal challenge with al- 
ginate beads containing I? aemginoso (lo9 CFU/ml). The drugs were 
administered subcutaneously once a day for ten days starting at the 
day of challenge. Two weeks after challenge, lung histopathology, 
bacterial clearance, serum antibody response etc. were evaluated. 
Results: Bacterial clearance was improved in all three treated 
groups (p 0.05, p < 0.02, p c 0.01) compared to the control. I? 
aeruginosa was detected in all 10 control rats (100%) and only 2 out 
of 5 rats (40%) in the SHL (p < 0.01). The severity of gross lung 
pathology in all three herbal groups decreased (p < 0.02, p < 0.005, 
p < 0.005) and the lymphocyte% in peripheral blood increased (p < 
0.05, p < 0.01, p < 0.005) in comparison with the controls. In the 
SHL treated group, the neutmphd% in peripheral blood, the serum 
